Guanylatecyclase-activating peptide II (human) (9CI)(196883-78-0)
- Name: Guanylatecyclase-activating peptide II (human) (9CI)
- Synonyms:Guanylatecyclase-activating peptide II (human reduced), cyclic (12®20),(15®23)-bis(disulfide)
- Molecular Formula:C108H176 N30 O36 S4
- Molecular Weight:
- CAS Registry Number:196883-78-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.196883-78-0 Guanylatecyclase-activating peptide II (human) (9CI)
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]
Other Product
- 89698-27-1/Benzene,(1-methylethenyl)-, hexamer
- 105296-07-9/N-[3-[4-(diethylamino)-2-methyl-phenyl]imino-4-methyl-6-oxo-cyclohexa-1,4-dien-1-yl]acetamide
- 71839-44-6/1H,3H-Benzo(1,2-c:4,5-c)difuran-1,3,5,7-tetrone, polymer with 4,4-oxybis(benzenamine), 2-(2-methyl-1-oxopropoxy)ethyl ester
- 53391-04-1/bis(naphthalen-1-ylmethyl)diselane
- 85118-39-4/1,3-dimethylbutyl 2-ethylhexanoate
- 37874-20-7/Spiro[1-azabicyclo[2.2.2]octane-3,4'-imidazolidin]-2'-one hydrochloride
- 212773-42-7/b-D-Glucopyranoside,(1S,4E,8E,12Z)-14-[[6-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-1-ethenyl-1,5,9,13-tetramethyl-4,8,12-tetradecatrienyl4-O-(6-deoxy-a-L-mannopyranosyl)-(9CI)
- 82318-19-2/diethyl N-(4-{[(4-methylphenyl)sulfonyl](octyl)amino}benzoyl)glutamate
- 23328-87-2/2-HEPTADECYLIMIDAZOLE
- 16566-96-4/5,7,7-trimethyl-6,8-dioxabicyclo[3.2.1]octane
- 135970-38-6/1-Cyclohexene-1-carboxylicacid, 4-(4-hydroperoxy-1-hydroxy-1,5-dimethyl-5-hexenyl)-, methyl ester (9CI)
- 68783-57-3/Fatty acids, vegetable-oil, compds. with triethanolamine
- 59137-99-4/5-(cyclohex-1-en-1-ylmethyl)pyrimidine-2,4(1H,3H)-dione
- 23651-62-9/ethyl N-ethyl-beta-alaninate
- 5170-27-4/N-(2-methoxy-2-phenylethyl)benzenesulfonamide
- 23572-63-6/4-amino-5-(3,4-dichlorophenyl)-1-(3-phenoxypropyl)pyrimidin-2(1H)-one
- 76755-68-5/Isocyanic acid, polymethylenepolyphenylene ester, polymer with 1,1'-methylenebis[4-isocyanatobenzene], methyloxirane and oxirane
- 124222-16-8/Residues, copper-refining
- 59712-21-9/b-D-ribo-Hexopyranoside, (3b,5b,12b,14b,17b)-12,14-dihydroxy-17-(4-pyridazinyl)androstan-3-ylO-2,6-dideoxy-b-D-ribo-hexopyranosyl-(1®4)-O-2,6-dideoxy-b-D-ribo-hexopyranosyl-(1®4)-2,6-dideoxy- (9CI)
- 196883-78-0/Guanylatecyclase-activating peptide II (human) (9CI)
- 15565-23-8/9,10-dimethoxy-3-(2-methylpropyl)-2,2-bis(methylsulfanyl)-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinoline hydrochloride (1:1)
- 37497-56-6/2-bromooxirane
- 137918-89-9/N-{7-[4-(dimethylamino)phenyl]-5-oxo-2,3,6,7-tetrahydro-5H-imidazo[2,1-b][1,3]thiazin-6-yl}benzamide
- 6323-70-2/N,N-di(propan-2-yl)hept-2-yn-1-amine
- 102616-50-2/sodium 5-[(4-chloro-6-phenyl-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-phenylazo-7-sulfo-naphthalene-2-sulfonate
- 84423-90-5/2-(2-hydroxyethyl)-5,6-bis(4-methoxyphenyl)-1,2,4-triazin-3(2H)-one
- 116357-66-5/promagainin
- 828-40-0/Benzeneacetamide, a-ethyl-a-methyl-
- 55555-34-5/4H-1-Benzopyran-4-one,8-b-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-
- 2077-92-1/Acetamide,N,N'-trans-1,4-cyclohexanediylbis- (9CI)